GenMont Biotech Inc Financial Flexibility Index
GenMont Biotech Inc financial flexibility index. GenMont Biotech Inc (3164) has a Financial Flexibility Index of 0.05x as of March 2026. Free cash flow of NT$15.69 Million (operating CF NT$15.46 Million minus capex NT$230.00K) represents 0% of total liabilities (NT$297.05 Million). See GenMont Biotech Inc (3164) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of GenMont Biotech Inc (2005–2025)
Financial flexibility index of GenMont Biotech Inc from 2005 to 2025. Historical Financial Flexibility Index trend for GenMont Biotech Inc across 21 annual periods. Check GenMont Biotech Inc (3164) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
GenMont Biotech Inc Financial Flexibility Index by Year (2005–2025)
GenMont Biotech Inc financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for GenMont Biotech Inc. For the full cash flow conversion analysis, see cash flow conversion of GenMont Biotech Inc.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.36x | NT$77.25 Million | NT$73.60 Million | NT$215.35 Million | ▼ -51.2% |
| 2024 | 0.73x | NT$168.22 Million | NT$123.95 Million | NT$229.06 Million | ▲ +113.7% |
| 2023 | 0.34x | NT$70.14 Million | NT$34.60 Million | NT$204.06 Million | ▼ -67.3% |
| 2022 | 1.05x | NT$208.88 Million | NT$137.95 Million | NT$198.59 Million | ▼ -20.2% |
| 2021 | 1.32x | NT$228.77 Million | NT$111.66 Million | NT$173.65 Million | ▼ -32.9% |
| 2020 | 1.96x | NT$257.26 Million | NT$118.27 Million | NT$130.95 Million | ▼ -48.4% |
| 2019 | 3.81x | NT$468.23 Million | NT$74.52 Million | NT$123.04 Million | ▲ +9.8% |
| 2018 | 3.47x | NT$331.33 Million | NT$56.03 Million | NT$95.60 Million | ▲ +323.9% |
| 2017 | 0.82x | NT$105.81 Million | NT$77.56 Million | NT$129.41 Million | ▲ +30.3% |
| 2016 | 0.63x | NT$77.91 Million | NT$45.34 Million | NT$124.14 Million | ▲ +331.3% |
| 2015 | 0.15x | NT$19.42 Million | NT$-5.01 Million | NT$133.43 Million | ▲ +180.6% |
| 2014 | -0.18x | NT$-26.14 Million | NT$-62.00 Million | NT$144.76 Million | ▼ -187.4% |
| 2013 | 0.21x | NT$110.91 Million | NT$100.37 Million | NT$536.49 Million | ▲ +627.8% |
| 2012 | -0.04x | NT$-22.19 Million | NT$-23.58 Million | NT$566.61 Million | ▼ -149.0% |
| 2011 | 0.08x | NT$47.03 Million | NT$39.94 Million | NT$588.06 Million | ▼ -77.0% |
| 2010 | 0.35x | NT$218.35 Million | NT$200.03 Million | NT$627.66 Million | ▼ -76.3% |
| 2009 | 1.47x | NT$130.06 Million | NT$108.53 Million | NT$88.42 Million | ▼ -25.5% |
| 2008 | 1.97x | NT$140.91 Million | NT$100.62 Million | NT$71.36 Million | ▼ -13.8% |
| 2007 | 2.29x | NT$107.72 Million | NT$43.36 Million | NT$47.04 Million | ▲ +311.5% |
| 2006 | 0.56x | NT$32.93 Million | NT$29.56 Million | NT$59.18 Million | ▼ -17.4% |
| 2005 | 0.67x | NT$15.76 Million | NT$9.53 Million | NT$23.41 Million | — |